Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Clinical pharmacokinetic and safety data reported for insulin detemir

Sep. 10, 2002

New data support single daily doses of LY-307161 SR to treat type 2 diabetes

Sep. 10, 2002

Bupropion reported to enhance weight loss in dieting patients with depressive symptoms

Sep. 10, 2002

Weight-lowering effects of anticonvulsants

Sep. 10, 2002

Combining A-200, ephedrine and caffeine does not enhance weight loss in obese patients

Sep. 10, 2002

Weight loss induced by Axokine is maintained for a year after end of treatment

Sep. 10, 2002

Symlin dose-titration study fully enrolled

Sep. 9, 2002

Improved oral bioavailability achieved in dihydropyridine Y1 receptor antagonists

Sep. 9, 2002

ATL-962 significantly increases fat excretion in phase Ib studies

Sep. 9, 2002

Rosuvastatin: superior cholesterol control compared to atorvastatin and potential in stroke

Sep. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...